Corvus Pharmaceuticals, Inc.CRVSNASDAQ
Loading
Total Costs & Expenses Over TimeExpanding
Percentile Rank64
3Y CAGR+9.7%
5Y CAGR-0.4%
Studio
Year-over-Year Change

Total of all costs and expenses

3Y CAGR
+9.7%/yr
vs -9.8%/yr prior
5Y CAGR
-0.4%/yr
Recent acceleration
Acceleration
+19.5pp
Accelerating
Percentile
P64
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$42.97M+56.0%
2024$27.55M+17.7%
2023$23.41M-28.1%
2022$32.56M-15.7%
2021$38.63M-11.7%
2020$43.76M-10.4%
2019$48.85M-0.7%
2018$49.22M-12.9%
2017$56.52M+52.9%
2016$36.98M-